
Ashwin N Ananthakrishnan MD MPH
Inflammatory Bowel Disease
Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School.
Join to View Full Profile
165 Cambridge StreetBoston, MA 02114
Phone+1 617-726-0267
Dr. Ananthakrishnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Gastroenterology, 2007 - 2010
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2004 - 2007
- Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 2003
Certifications & Licensure
- ME State Medical License 2021 - 2026
- MA State Medical License 2010 - 2025
- NH State Medical License 2021 - 2025
- RI State Medical License 2021 - 2024
- WI State Medical License 2005 - 2011
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease Start of enrollment: 2017 Nov 13
- Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) Start of enrollment: 2018 Nov 10
Publications & Presentations
PubMed
- Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and pr...Siddharth Singh, Jasmine D Nguyen, David I Fudman, Mark E Gerich, Samir A Shah
BMJ Open Gastroenterology. 2025-03-31 - The Ulcerative Colitis-Associated Gene NXPE1 Catalyzes Glycan Modifications on Colonic Mucin.Ranad Humeidi, Noriko Oshiro-Rapley, Xiebin Gu, Joon Soo An, Ashwin N Ananthakrishnan
Journal of the American Chemical Society. 2025-03-26 - Publisher Correction: Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities.Iliyan D Iliev, Ashwin N Ananthakrishnan, Chun-Jun Guo
Nature Reviews. Microbiology. 2025-03-24
Journal Articles
- CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis PatientsMichael S Gee, Ashwin N Ananthakrishnan, Digestive Diseases and Sciences
- Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women Without Celiac Disease: A Prospective Cohort StudyBenjamin Lebwohl, Paul Lochhead, Ashwin N Ananthakrishnan, Andrew T Chan, Kristin E Burke, James M Richter, Hamed Khalili, Nature
- Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative ColitisJay Luther, Francis Colizzo, Ashwin N Ananthakrishnan, Amar Vedamurthy, John J Garber, Hamed Khalili, Digestive Diseases and Sciences
- Join now to see all
Press Mentions
- Does Bezlotoxumab Boost FMT Efficacy in IBD Patients with Recurrent CDI?November 11th, 2024
- ACG/ASGE Task Force Identifies 19 Indicators for Achieving Quality GI EndoscopySeptember 11th, 2024
- New Guidelines Recommend Stool and Blood Tests to Monitor Ulcerative ColitisFebruary 24th, 2023
- Join now to see all
Grant Support
- Determinants of inception of inflammation in inflammatory bowel diseasesMASSACHUSETTS GENERAL HOSPITAL2021–2026
- Determinants of inception of inflammation in inflammatory bowel diseasesMASSACHUSETTS GENERAL HOSPITAL2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: